A new study from mcgill university finds no association between glp-1 drugs like ozempic and suicide risk, providing reassurance about the psychiatric safety of these medications.

Discussed in relation to the risk of suicide and use as a GLP-1 drug.

Conducted the study finding no link between glp-1 drugs and suicide risk.

Published the study conducted by mcgill university.

Active ingredient in ozempic and mentioned in the context of lower suicide ideation risk.

Updated the list of potential risks associated with glp-1 drugs.